Back to Search
Start Over
Dismal outcomes of patients with relapsed/refractory Philadelphia chromosome‐negative B‐cell acute lymphoblastic leukemia after failure of both inotuzumab ozogamicin and blinatumomab.
- Source :
- American Journal of Hematology; Jun2022, Vol. 97 Issue 6, pE201-E204, 4p
- Publication Year :
- 2022
Details
- Language :
- English
- ISSN :
- 03618609
- Volume :
- 97
- Issue :
- 6
- Database :
- Complementary Index
- Journal :
- American Journal of Hematology
- Publication Type :
- Academic Journal
- Accession number :
- 156869851
- Full Text :
- https://doi.org/10.1002/ajh.26526